BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2022710)

  • 1. Solitary polyclonal autonomous thyroid nodule: a rare cause of childhood hyperthyroidism.
    Namba H; Ross JL; Goodman D; Fagin JA
    J Clin Endocrinol Metab; 1991 May; 72(5):1108-12. PubMed ID: 2022710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal composition of benign and malignant human thyroid tumors.
    Namba H; Matsuo K; Fagin JA
    J Clin Invest; 1990 Jul; 86(1):120-5. PubMed ID: 1973172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of thyroid autonomy and hot nodules.
    Corvilain B
    Ann Endocrinol (Paris); 2003 Feb; 64(1):17-22. PubMed ID: 12707627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal analysis of solitary follicular nodules in the thyroid.
    Hicks DG; LiVolsi VA; Neidich JA; Puck JM; Kant JA
    Am J Pathol; 1990 Sep; 137(3):553-62. PubMed ID: 1975986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomas.
    Hébrant A; Van Sande J; Roger PP; Patey M; Klein M; Bournaud C; Savagner F; Leclère J; Dumont JE; van Staveren WC; Maenhaut C
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2602-9. PubMed ID: 19383781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
    Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].
    Derwahl M
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autonomous nodule of the thyroid: correlation of patient age, nodule size and functional status.
    Blum M; Shenkman L; Hollander CS
    Am J Med Sci; 1975; 269(1):43-50. PubMed ID: 1130435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal composition of human adrenocortical neoplasms.
    Beuschlein F; Reincke M; Karl M; Travis WD; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
    Cancer Res; 1994 Sep; 54(18):4927-32. PubMed ID: 7915195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras mutations are rare in solitary cold and toxic thyroid nodules.
    Krohn K; Reske A; Ackermann F; Müller A; Paschke R
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):241-8. PubMed ID: 11531932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal analysis of a solitary follicular nodule of the thyroid with the polymerase chain reaction method.
    Chung DH; Kang GH; Kim WH; Ro JY
    Mod Pathol; 1999 Mar; 12(3):265-71. PubMed ID: 10102611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autonomous thyroid adenoma in an 11 years old girl with childhood hyperthyroidism (author's transl)].
    Zach M; Falk W
    Monatsschr Kinderheilkd (1902); 1977 Apr; 125(4):207-10. PubMed ID: 854033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
    Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coincidental thyroid papillary microcarcinoma in a patient treated for a toxic adenoma of the thyroid.
    Polyzos SA; Goulis DG
    Arch Iran Med; 2011 Mar; 14(2):149-51. PubMed ID: 21361725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic thyroid cancer with severe hyperthyroidism mimicking independent hyperfunctioning thyroid adenoma, showing transition to water-clear-tumour.
    Nĕmec J; Zeman V; Nahodil V; Vána S; Zamrazil V; Smejkal V; Shameti H; Trnka V
    Endokrinologie; 1980 Mar; 75(2):197-204. PubMed ID: 7398590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of c-Ras in hyperplasia and adenomas of the feline thyroid gland: an immunohistochemical analysis of 34 cases.
    Merryman JI; Buckles EL; Bowers G; Neilsen NR
    Vet Pathol; 1999 Mar; 36(2):117-24. PubMed ID: 10098639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coexistence of hyperthyroidism and thyroid carcinoma. Description of a clinical case].
    De Marinis L; Mancini A; Tofani A; Calabrò F; Sciuto R; Bellantone R; Sofo L; Goglia A; Rabitti C; Montemaggi P
    Minerva Endocrinol; 1989; 14(2):129-35. PubMed ID: 2761496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomous adenomas caused by somatic mutations of the thyroid-stimulating hormone receptor in children.
    Grob F; Deladoëy J; Legault L; Spigelblatt L; Fournier A; Vassart G; Van Vliet G
    Horm Res Paediatr; 2014; 81(2):73-9. PubMed ID: 24480816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.